Copyright
©The Author(s) 2016.
World J Hepatol. Feb 28, 2016; 8(6): 331-339
Published online Feb 28, 2016. doi: 10.4254/wjh.v8.i6.331
Published online Feb 28, 2016. doi: 10.4254/wjh.v8.i6.331
Figure 1 Study design.
BOC: Boceprevir; D/c: Discontinued; HCV: Hepatitis C virus; PR: Peginterferon/ribavirin; TW: Treatment week.
- Citation: Isakov V, Nikitin I, Chulanov V, Ogurtsov P, Lukyanova E, Long J, Wahl J, Helmond FA, The P08160 Trial Investigators. Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia. World J Hepatol 2016; 8(6): 331-339
- URL: https://www.wjgnet.com/1948-5182/full/v8/i6/331.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i6.331